Licensing, Partnering, Strategic Alliances and University Relationships

Authors

  • Wesley Daniel Blakeslee Johns Hopkins University

DOI:

https://doi.org/10.5912/jcb500

Keywords:

University, Technology Transfer, Industry, Commercialization, Collaboration

Abstract

Abstract

 

The biopharmaceutical industry has been undergoing change for a number of years and that change is accelerating.  Larger pharmaceutical companies are acquiring smaller ones, companies are merging, laboratories are being closed, and the number of scientists performing research in the pharmaceutical industry is declining.  Overall, commercial industry, including the biotechnology industry, is becoming more interested in the benefits of collaboration with research institutions.

Universities are also changing their view of relationships with industry.  Shrinking federal budgets are causing universities to look at other sources of revenue, including collaborations with industry.  Federal and state governments are also looking closely at the benefits of sponsoring university research, and in particular are seeking to accelerate commercialization of university discoveries not only to obtain the benefit of invested research dollars, but also for economic development and job growth.  Universities, and in particular university technology transfer offices, must understand these changes and adapt to them. 

This paper discusses the university/industry relationships, and the particular issues important to universities which shape that interface. 

Author Biography

  • Wesley Daniel Blakeslee, Johns Hopkins University

    Wesley D. Blakeslee is Executive Director of Johns Hopkins Technology Transfer.  He holds an engineering degree (with Honors) from Penn State University, and a law degree (Honors – Order of the Coif), from the University of Maryland School of Law and is a Certified Licensing Professional.  Wes is a former engineer and systems analyst with NASA.  He has been a Director of a national bank, and served as Director of Computer Development at the University Of Maryland School Of Law where he also taught Computer Law.   Wes joined Johns Hopkins in 1999 as Associate General Counsel.

References

Littman, Bruce H. and Marincola, Francesco M., (2011) Editorial: Create A Translational Medicine Knowledge Repository. Journal of Translational Medicine 9:56

The New Economy (2010) Big Pharma’s Stalled R & D Machine, 16 June,

http://www.theneweconomy.com/science-and-technology/pharmaceuticals/542-big-pharmas-stalled-rd-machine/, accessed October 31, 2011.

Kling, Jim (2011) Biotechs Follow Big Pharma Lead Back Into Academia. Nature Biotechnology 29: 555–556

Rev. Proc. 2007 – 47.

Downloads

Published

2012-04-01

Issue

Vol. 18 No. 2 (2012)

Section

Special Section